keyword
https://read.qxmd.com/read/38600329/revolutionizing-knee-osteoarthritis-treatment-innovative-self-nano-emulsifying-polyethylene-glycol-organogel-of-curcumin-for-effective-topical-delivery
#21
JOURNAL ARTICLE
Mahtab Baharizade, Seyed Iman Ghetmiri, Mohsen Mohammady, Soliman Mohammadi-Samani, Gholamhossein Yousefi
In the current study, self-nano-emulsifying (SNE) physically cross-linked polyethylene glycol (PEG) organogel (SNE-POG) as an innovative hybrid system was fabricated for topical delivery of water-insoluble and unstable bioactive compound curcumin (CUR). Response surface methodology (RSM) based on Optimal Design was utilized to evaluate the formulation factors. Solid fiber mechanism with homogenization was used to prepare formulations. Pharmaceutical evaluation including rheological and texture analysis, their mathematical correlations besides physical and chemical stability experiments, DSC study, in vitro release, skin permeation behavior, and clinical evaluation were carried out to characterize and optimize the SNE-OGs...
April 10, 2024: AAPS PharmSciTech
https://read.qxmd.com/read/38598464/deep-learning-to-predict-rapid-progression-of-alzheimer-s-disease-from-pooled-clinical-trials-a-retrospective-study
#22
JOURNAL ARTICLE
Xiaotian Ma, Madison Shyer, Kristofer Harris, Dulin Wang, Yu-Chun Hsu, Christine Farrell, Nathan Goodwin, Sahar Anjum, Avram S Bukhbinder, Sarah Dean, Tanveer Khan, David Hunter, Paul E Schulz, Xiaoqian Jiang, Yejin Kim
The rate of progression of Alzheimer's disease (AD) differs dramatically between patients. Identifying the most is critical because when their numbers differ between treated and control groups, it distorts the outcome, making it impossible to tell whether the treatment was beneficial. Much recent effort, then, has gone into identifying RPs. We pooled de-identified placebo-arm data of three randomized controlled trials (RCTs), EXPEDITION, EXPEDITION 2, and EXPEDITION 3, provided by Eli Lilly and Company. After processing, the data included 1603 mild-to-moderate AD patients with 80 weeks of longitudinal observations on neurocognitive health, brain volumes, and amyloid-beta (Aβ) levels...
April 2024: PLOS Digit Health
https://read.qxmd.com/read/38597988/oral-delta-9-tetrahydrocannabinol-thc-increases-parasympathetic-activity-and-supraspinal-conditioned-pain-modulation-in-chronic-neuropathic-pain-male-patients-a-crossover-double-blind-placebo-controlled-trial
#23
JOURNAL ARTICLE
Libat Weizman, Haggai Sharon, Lior Dayan, Joumana Espaniol, Silviu Brill, Hadas Nahman-Averbuch, Talma Hendler, Giris Jacob
BACKGROUND: Disordered autonomic nervous system regulation and supraspinal pain inhibition have been repeatedly described in chronic pain. We aimed to explore the effects of δ-9-tetrahydrocannabinol (THC), an emerging treatment option, on autonomic nervous system and central pain modulation measures in patients with chronic pain. METHODS: Twelve male patients with chronic radicular neuropathic pain participated in a randomized, double-blind, crossover, placebo-controlled, single-administration trial...
April 10, 2024: CNS Drugs
https://read.qxmd.com/read/38596369/effects-of-bacillus-coagulans-tbc169-on-gut-microbiota-and-metabolites-in-gynecological-laparoscopy-patients
#24
JOURNAL ARTICLE
Weiqi Gao, Ya Yan, Zhaobo Guan, Jingmin Zhang, Weihong Chen
OBJECTIVE: The primary objective of this study is to investigate the mechanism by which Bacillus coagulans TBC169 accelerates intestinal function recovery in patients who have undergone gynecological laparoscopic surgery, using metabolomics and gut microbiota analysis. METHODS: A total of 20 subjects were selected and randomly divided into two groups: the intervention group ( n  = 10) receiving Bacillus coagulans TBC169 Tablets (6 pills, 1.05 × 108  CFU), and the control group ( n  = 10) receiving placebos (6 pills)...
2024: Frontiers in Microbiology
https://read.qxmd.com/read/38593705/the-impact-of-daily-supplementation-with-rhamnogalacturonan-i-on-the-gut-microbiota-in-healthy-adults-a-randomized-controlled-trial
#25
JOURNAL ARTICLE
Ching Jian, Nikolaj Sorensen, René Lutter, Ruud Albers, Willem de Vos, Anne Salonen, Annick Mercenier
Pectin and its derivatives have been shown to modulate immune signaling as well as gut microbiota in preclinical studies, which may constitute the mechanisms by which supplementation of specific pectic polysaccharides confers protection against viral respiratory infections. In a double-blind, placebo-controlled rhinovirus (RV16) challenge study, healthy volunteers were randomized to consume placebo (0.0 g/day) (N = 46), low-dose (0.3 g/day) (N = 49) or high-dose (1.5 g/day) (N = 51) of carrot derived rhamnogalacturonan-I (cRG-I) for eight weeks and they were subsequently challenged with RV-16...
April 8, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38593477/debamestrocel-multimodal-effects-on-biomarker-pathways-in-amyotrophic-lateral-sclerosis-are-linked-to-clinical-outcomes
#26
JOURNAL ARTICLE
Stacy R Lindborg, Namita A Goyal, Jonathan Katz, Matthew Burford, Jenny Li, Haggai Kaspi, Natalie Abramov, Bruno Boulanger, James D Berry, Katharine Nicholson, Tahseen Mozaffar, Robert Miller, Liberty Jenkins, Robert H Baloh, Richard Lewis, Nathan P Staff, Margaret Ayo Owegi, Bob Dagher, Netta R Blondheim-Shraga, Yael Gothelf, Yossef S Levy, Ralph Kern, Revital Aricha, Anthony J Windebank, Robert Bowser, Robert H Brown, Merit E Cudkowicz
INTRODUCTION/AIMS: Biomarkers have shown promise in amyotrophic lateral sclerosis (ALS) research, but the quest for reliable biomarkers remains active. This study evaluates the effect of debamestrocel on cerebrospinal fluid (CSF) biomarkers, an exploratory endpoint. METHODS: A total of 196 participants randomly received debamestrocel or placebo. Seven CSF samples were to be collected from all participants. Forty-five biomarkers were analyzed in the overall study and by two subgroups characterized by the ALS Functional Rating Scale-Revised (ALSFRS-R)...
April 9, 2024: Muscle & Nerve
https://read.qxmd.com/read/38593352/molnupiravir-mechanism-of-action-clinical-and-translational-science
#27
REVIEW
Brian M Maas, Julie Strizki, Randy R Miller, Sushma Kumar, Michelle Brown, Matthew G Johnson, Mickie Cheng, Carisa De Anda, Matthew L Rizk, Julie A Stone
Molnupiravir is an oral prodrug of the broadly active, antiviral ribonucleoside analog N-hydroxycytidine (NHC). The primary circulating metabolite NHC is taken up into cells and phosphorylated to NHC-triphosphate (NHC-TP). NHC-TP serves as a competitive substrate for viral RNA-dependent RNA polymerase (RdRp), which results in an accumulation of errors in the viral genome, rendering virus replication incompetent. Molnupiravir has demonstrated activity against SARS-CoV-2 both clinically and preclinically and has a high barrier to development of viral resistance...
February 2024: Clinical and Translational Science
https://read.qxmd.com/read/38593220/long-covid-and-post-acute-sequelae-of-sars-cov-2-pathogenesis-and-treatment-a-keystone-symposia-report
#28
JOURNAL ARTICLE
Matthew S Durstenfeld, Shannon Weiman, Michael Holtzman, Catherine Blish, Resia Pretorius, Steven G Deeks
In 2023, the Keystone Symposia held the first international scientific conference convening research leaders investigating the pathology of post-acute sequelae of COVID-19 (PASC) or Long COVID, a growing and urgent public health priority. In this report, we present insights from the talks and workshops presented during this meeting and highlight key themes regarding what researchers have discovered regarding the underlying biology of PASC and directions toward future treatment. Several themes have emerged in the biology, with inflammation and other immune alterations being the most common focus, potentially related to viral persistence, latent virus reactivation, and/or tissue damage and dysfunction, especially of the endothelium, nervous system, and mitochondria...
April 9, 2024: Annals of the New York Academy of Sciences
https://read.qxmd.com/read/38591664/inhaled-bronchodilators-for-the-prevention-and-treatment-of-chronic-lung-disease-in-preterm-infants
#29
REVIEW
Geraldine Ng, Matteo Bruschettini, John Ibrahim, Orlando da Silva
BACKGROUND: Chronic lung disease (CLD) occurs frequently in preterm infants and is associated with respiratory morbidity. Bronchodilators have the potential effect of dilating small airways with muscle hypertrophy. Increased compliance and tidal volume, and decreased airway resistance, have been documented with the use of bronchodilators in infants with CLD. Therefore, bronchodilators are widely considered to have a role in the prevention and treatment of CLD, but there remains uncertainty as to whether they improve clinical outcomes...
April 9, 2024: Cochrane Database of Systematic Reviews
https://read.qxmd.com/read/38588964/equivalence-of-single-and-standard-doses-of-antenatal-corticosteroids-for-late-preterm-neonatal-outcomes-insights-from-a-secondary-analysis
#30
JOURNAL ARTICLE
Yossi Bart, Suneet P Chauhan, Michal Fishel Bartal, Sean Blackwell, Baha M Sibai
BACKGROUND: The recent paradigm shift of treating individuals at risk of late preterm birth with antenatal corticosteroids warrants an assessment of the effect of single dosage. OBJECTIVE: To compare outcomes of neonates born in the late preterm period (34.0-36.6 weeks) following a single dose of antenatal corticosteroids versus placebo. STUDY DESIGN: We performed a secondary analysis of the Antenatal Late Preterm Steroids (ALPS) trial (Gyamfi-Bannerman C...
April 6, 2024: American Journal of Obstetrics and Gynecology
https://read.qxmd.com/read/38585865/dapagliflozin-reduces-systemic-inflammation-in-patients-with-type-2-diabetes-without-known-heart-failure
#31
Dennis Wang, Anna Naumova, Daniel Isquith, Jaime Sapp, Kim Anh Huynh, Isabella Tucker, Niranjan Balu, Anna Voronyuk, Baocheng Chu, Karen Ordovas, Charles Maynard, Rong Tian, Xue-Qiao Zhao, Francis Kim
OBJECTIVE: Sodium glucose cotransporter 2 (SGLT2) inhibitors significantly improve cardiovascular outcomes in diabetic patients; however, the mechanism is unclear. We hypothesized that dapagliflozin improves cardiac outcomes via beneficial effects on systemic and cardiac inflammation and cardiac fibrosis. RESEARCH AND DESIGN METHODS: This randomized placebo-controlled clinical trial enrolled 62 adult patients (mean age 62, 17% female) with type 2 diabetes (T2D) without known heart failure...
March 25, 2024: Research Square
https://read.qxmd.com/read/38584862/the-effect-of-singular-nonverbal-behaviours-of-experimenters-on-pain-reports
#32
JOURNAL ARTICLE
Hojjat Daniali, Mollie A Ruben, Per M Aslaksen, Charlotte Fiskum, Ted J Kaptchuk, Magne A Flaten
INTRODUCTION: Studies suggest facial expressions of caregivers may be important in placebo effects; however, this has not been systematically tested. This experiment investigated the effects of caregivers' singular positive nonverbal behaviours (NBs) on pain reports. METHODS: Fifty-one males and 53 females (total of 104) participants were randomized to four groups that were displayed positive facial expressions, tone of voice, body movement, or neutral NBs of videotaped experimenters...
2024: Journal of Pain Research
https://read.qxmd.com/read/38582874/effects-of-transcutaneous-electrical-nerve-stimulation-on-pain-function-and-descending-inhibition-in-people-with-non-specific-chronic-low-back-pain-a-study-protocol-for-a-randomized-crossover-trial
#33
JOURNAL ARTICLE
Richard E Liebano, Kathleen A Sluka, Joshua Roy, Meghan Savinelli, Dana L Dailey, Sean P Riley
BACKGROUND: Low back pain (LBP) is a significant public health problem, is very prevalent, and is often characterized by the persistence of symptoms. Transcutaneous electrical nerve stimulation (TENS) may benefit people with chronic LBP because it can activate descending inhibitory pathways and inhibit central excitability. However, previous studies that have investigated the effects of TENS on pain in people with LBP have failed to use proper intensities of current, and the timing of the assessment of pain was not performed during the peak of the analgesic response or functional activities...
April 6, 2024: Trials
https://read.qxmd.com/read/38582287/the-effectiveness-of-hypnoanalgesia-using-conventional-and-placebo-hypnosis-induction
#34
JOURNAL ARTICLE
Zoltan Kekecs, Balazs Nyiri, Cameron Alldredge, Boglarka Cserni, Pietro Rizzo, Balint Domok, Vanda Vizkievicz, Aliz Takacs, Kyra Giran, Judit Krisztina Nagy, Gary Elkins
The effectiveness of hypnosis-based pain management is well established. However, mechanisms of action and specific effective components are not well understood. The socio-cognitive theory of hypnosis proposes that the effectiveness of hypnosis for pain management is determined by the non-specific features of response expectancy and context. We tested this claim by contrasting the effectiveness of two hypnoanalgesia procedures in a within subjects design using the cold pressor task. The two procedures were identical, including analgesic suggestions, except for the hypnosis induction used...
April 4, 2024: Journal of Pain
https://read.qxmd.com/read/38581102/proton-pump-inhibitors-for-gastrointestinal-bleeding-prophylaxis-in-critically-ill-patients-a-systematic-review-protocol
#35
REVIEW
Ying Wang, Diane Heels-Ansdell, Long Ge, Sameer Parpia, Quazi Ibrahim, Deborah Cook, Adam Deane, Francois Lauzier, Naomi Hammond, Morten H Møller, Mette Krag, Anders Perner, Gordon H Guyatt
BACKGROUND: Proton pump inhibitors (PPIs) are the most commonly prescribed drugs for preventing upper gastrointestinal bleeding in critically ill patients. However, concerns have arisen about the possible harms of using PPIs, including potentially increased risk of pneumonia, Clostridioides difficile infection, and more seriously, an increased risk of death in the most severely ill patients. Triggered by the REVISE trial, which is a forthcoming large randomized trial comparing pantoprazole to placebo in invasively mechanically ventilated patients, we will conduct this systematic review to evaluate the efficacy and safety of PPIs versus no prophylaxis for critically ill patients...
April 5, 2024: Acta Anaesthesiologica Scandinavica
https://read.qxmd.com/read/38578978/oral-daily-pth-1-34-tablets-eb613-in-postmenopausal-women-with-low-bmd-or-osteoporosis-a-randomized-placebo-controlled-six-month-phase-2-study
#36
JOURNAL ARTICLE
Liana Tripto-Shkolnik, Auryan Szalat, Gloria Tsvetov, Vanessa Rouach, Chana Sternberg, Anke Hoppe, Gregory Burshtein, Hillel Galitzer, Miranda Toledano, Gil Harari, Arthur C Santora, Felicia Cosman
Anabolic treatment is indicated for high and very-high risk patients with osteoporosis, but acceptance is limited because current anabolic medications require subcutaneous injections. The purpose of this study was to assess the effects of a novel orally administered parathyroid hormone (PTH) tablet on serum markers of bone formation [N-terminal propeptide of Type I procollagen (PINP) and osteocalcin (OC)] and bone resorption [crosslinked C-telopeptide (CTX)], bone mineral density (BMD) and safety in postmenopausal women with low BMD or osteoporosis...
April 5, 2024: Journal of Bone and Mineral Research
https://read.qxmd.com/read/38577951/placebo-effects-are-small-on-average-in-the-7-5-co2-inhalational-model-of-generalised-anxiety
#37
JOURNAL ARTICLE
Nathan T M Huneke, Cosmina Cross, Harry A Fagan, Laura Molteni, Naomi Phillips, Matthew Garner, David S Baldwin
BACKGROUND: Anxiety disorders are highly prevalent and socio-economically costly. Novel pharmacological treatments for these disorders are needed as many patients do not respond to current agents or experience unwanted side-effects. However, a barrier to treatment development is the variable and large placebo response rate seen in trials of novel anxiolytics. Despite this, the mechanisms that drive placebo responses in anxiety disorders have been little investigated, possibly due to low availability of convenient experimental paradigms...
April 5, 2024: International Journal of Neuropsychopharmacology
https://read.qxmd.com/read/38574852/neurochemical-mechanisms-underlying-serotonergic-modulation-of-neuroplasticity-in-humans
#38
JOURNAL ARTICLE
Lorena Melo, Marie C Beaupain, Elham Ghanavati, Min-Fang Kuo, Michael A Nitsche
BACKGROUND: Studies in animals and humans have shown that cortical neuroplasticity can be modulated by increasing serotonin levels by administering selective serotonin reuptake inhibitors (SSRI). However, little is known about the mechanistic background, especially the contribution of intracortical inhibition and facilitation, which depend on gamma-aminobutyric acid (GABA) and glutamate. OBJECTIVE: We aimed to explore the relevance of drivers of plasticity (glutamate- and GABA-dependent processes) for the effects of serotonin enhancement on tDCS-induced plasticity in healthy humans...
April 2, 2024: Brain Stimulation
https://read.qxmd.com/read/38572716/fecal-microbiota-transplantation-engraftment-after-budesonide-or-placebo-in-patients-with-active-ulcerative-colitis-using-pre-selected-donors-a-randomized-pilot-study
#39
JOURNAL ARTICLE
Emilie van Lingen, Sam Nooij, Elisabeth Terveer, Emily Crossette, Amanda Prince, Shakti Bhattarai, Andrea Watson, Gianluca Galazzo, Rajita Menon, Rose Szabady, Vanni Bucci, Jason Norman, Janneke van der Woude, Sander van der Marel, Hein Verspaget, Andrea van der Meulen-de Jong, Josbert Keller
BACKGROUND: Fecal microbiota transplantation (FMT) shows some efficacy in treating patients with ulcerative colitis (UC), although variability has been observed among donors and treatment regimens. We investigated the effect of FMT using rationally selected donors after pretreatment with budesonide or placebo in active UC. METHODS: Patients ≥ 18 years old with mild to moderate active UC were randomly assigned to three weeks budesonide (9 mg) or placebo followed by four weekly infusions of a donor feces suspension...
April 4, 2024: Journal of Crohn's & Colitis
https://read.qxmd.com/read/38571562/the-pharmacokinetics-and-pharmacodynamics-of-fentanyl-administered-via-transdermal-patch-in-horses
#40
JOURNAL ARTICLE
Rachel A Reed, Londa J Berghaus, Rose M Reynolds, Brittany T Holmes, Anna M Krikorian, Daniel M Sakai, Yushun Ishikawa, Heather K Knych
INTRODUCTION: Understanding the pharmacokinetics and pharmacodynamics of fentanyl in horses is crucial for optimizing pain management strategies in veterinary medicine. METHODS: Six adult horses were enrolled in a randomized crossover design. Treatments included: placebo, two 100 mcg/h patches (LDF), four 100 mcg/h patches (MDF), and six 100 mcg/h patches (HDF). Patches were in place for 72 h. Blood was obtained for fentanyl plasma concentration determination, thermal threshold, mechanical threshold, heart rate, respiratory rate, and rectal temperature were obtained prior patch placement and at multiple time points following patch placement for the following 96 h...
2024: Front Pain Res (Lausanne)
keyword
keyword
68773
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.